QIAGEN N.V. is a leading global provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is headquartered in Venlo, the Netherlands and has operations in over 35 countries worldwide. QIAGEN operates in the In Vitro Diagnostics sector, which involves the use of medical devices and reagents to perform tests on samples taken from the human body.

QIAGEN's mission is to enable customers to achieve outstanding success and breakthroughs in life sciences, molecular diagnostics and applied testing. The company's products and services are used by customers in a wide range of applications, including cancer diagnostics, infectious disease testing, genetic testing, and personalized medicine.

As a global company, QIAGEN is committed to decarbonisation and reducing its impact on the environment. The company has implemented a number of initiatives to reduce its carbon footprint, including the use of renewable energy sources and the implementation of energy-efficient technologies.

One of QIAGEN's key initiatives in this area is its Corporate Energy program, which aims to reduce the company's energy consumption and carbon emissions. The program includes a range of measures, such as the installation of energy-efficient lighting and heating systems, the use of renewable energy sources, and the implementation of energy management systems.

QIAGEN has also implemented a Corporate PPA (Power Purchase Agreement) program, which involves the purchase of renewable energy from external sources. The company has signed agreements with a number of renewable energy providers, including wind and solar power companies, to purchase energy from their facilities. This allows QIAGEN to reduce its reliance on fossil fuels and support the development of renewable energy infrastructure.

In addition to these initiatives, QIAGEN has also implemented a range of measures to reduce its overall environmental impact. The company has implemented a waste reduction program, which involves the recycling and reuse of materials wherever possible. QIAGEN has also implemented a water conservation program, which involves the use of water-efficient technologies and the reduction of water consumption in its operations.

QIAGEN's commitment to sustainability and decarbonisation is reflected in its corporate culture and values. The company has a dedicated Sustainability Committee, which is responsible for overseeing the implementation of sustainability initiatives across the organization. QIAGEN's sustainability strategy is aligned with the United Nations' Sustainable Development Goals, and the company is committed to achieving these goals by 2030.

In conclusion, QIAGEN N.V. is a leading global provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates in the In Vitro Diagnostics sector and is committed to reducing its impact on the environment through a range of initiatives, including the use of renewable energy sources, the implementation of energy-efficient technologies, and the reduction of waste and water consumption. QIAGEN's commitment to sustainability is reflected in its corporate culture and values, and the company is committed to achieving the United Nations' Sustainable Development Goals by 2030.